|
12:15
|
Lunch break
(until 13:45)
()
|
|
13:45
|
MEDICIS developments
(until 14:25)
()
|
|
13:45
|
Radiochemistry developments on Ra224
-
Muhammad Inzamam
(Pakistan Atomic Energy Commission (PK))
()
|
|
14:05
|
MEDICIS infrastructure and operational feedback
-
Laura Lambert
(CERN)
()
|
|
14:25
|
Recent achievements within the collaboration
(until 15:45)
()
|
|
14:25
|
MED-028 Study of the Ba-128/Cs-128 in vivo generator in a preclinical model of osteosarcoma.
-
David Viertl
()
|
|
14:45
|
MED-027 Strengthening theranostics or radionuclide therapy in Pakistan - Progress report
- Dr
Irfan Khan
(INMOL)
Qaiser Khan
(Pakistan Atomic Energy Commission (PK))
Muhammad Inzamam
(Pakistan Atomic Energy Commission (PK))
()
|
|
15:05
|
MED-015 44Sc production and study for clinical use - Progress Report
-
Patricija Kalnina
(University of Latvia (LV))
Edgars Mamis
(University of Latvia (LV))
()
|
|
15:25
|
MED-034 Determination of 227Ac impurity in 225Ac using alpha spectrometry - Written report
-
Marietta Straub
(Centre Hospitalier Universitaire Lausanne CHUV (CH))
Ruslan Cusnir
(IRA-CHUV)
()
|
|
15:45
|
Short break
(until 15:55)
()
|
|
15:55
|
New projects
(until 16:35)
()
|
|
15:55
|
MED-036 Clinical and Pre-clinical Evaluation of Tb155/161 Theranostic Pair for Imaging and Radionuclide Targeted Therapy of Tumors in Pakistan
- Dr
Irfan Khan
(INMOL)
Qaiser Khan
(Pakistan Atomic Energy Commission (PK))
()
|
|
16:15
|
MED-037 Alphamet LoI - metrology needs with alpha emitters
- Prof.
Michel Koole
(KULeuven)
Sean Collins
(National Physical Laboratory)
()
|
|
16:35
|
MEDICIS program in 2024
(until 17:05)
()
|
|
16:35
|
Program for 2024
-
Charlotte Duchemin
(CERN SY/STI/RBS)
()
|
|
17:05
|
AoB & Wrap-Up
(until 17:20)
()
|
